Diastolic Dysfunction Clinical Trial
Official title:
Early Detection of Diastolic Dysfunction and the Role of Lifestyle Measures in Its Treatment
The project aims to investigate the effect of a regular exercise for 6 months on diastolic parameters in patients who present with shortness of breath and who have evidence of early diastolic dysfunction on echocardiography. Patients will be enrolled from the VA General Medicine and Cardiology Clinics, and will be screened for diastolic dysfunction. Once enrolled, they will be on an exercise regimen that involves aerobic exercise for 30-45 minutes five times a week at home. The participants will have an initial supervised exercise session with the VA Cardiac Rehabilitation team, and will have either every other week or monthly supervised sessions at the VA Cardiac Rehabilitation Center to monitor their progress. Clinical, biometric, laboratory and echocardiographic parameters will be obtained before and after the 6 month period.
Status | Completed |
Enrollment | 9 |
Est. completion date | May 2011 |
Est. primary completion date | May 2010 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 40 Years to 65 Years |
Eligibility |
Inclusion Criteria: - Patients with dyspnea/shortness of breath - Age 40-65 years of age - Sedentary lifestyle (<150 minutes of exercise/week) - Echocardiographic evidence of early diastolic dysfunction: mitral E/A <0.9, OR resting E/E' between 8-15 cm/s, OR post-exercise E/E' >13 cm/s. Exclusion criteria: - Age <40 years or >65 years - Coronary Artery Disease by angiography or evidence of ischemia on a stress test - Systolic Dysfunction (LV Ejection fraction <50%) - Congestive Heart Failure Functional Class III or IV - Moderate to severe COPD (FEV <80% predicted) - Moderate to severe valvular heart disease, except tricuspid regurgitation - Inability to get heart rate >/= 85% of maximum predicted heart rate - Uncontrolled hypertension (systolic BP>140mmHg, diastolic BP>90mmHg) despite medical therapy - On echocardiogram, RV systolic pressure >60mmHg that suggests severe pulmonary hypertension - On echocardiogram, left atrial size> 6.5 cm or left atrial volume > 35 ml/BSA |
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Prevention
Country | Name | City | State |
---|---|---|---|
United States | Harry S Truman Veterans Administration Hospital | Columbia | Missouri |
Lead Sponsor | Collaborator |
---|---|
University of Missouri-Columbia |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Exercise echo Doppler will be done at baseline and after completion of 6 months of an exercise program | Beginning of study participation and after 6 months of study participation | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04558450 -
Covid-19 Effects on Arterial Stiffness and Vascular Aging (CARTESIAN)
|
N/A | |
Recruiting |
NCT02499601 -
CORolla® TAA for Heart Failure With Preserved Ejection Fraction (HFpEF) and Diastolic Dysfunction (DD)
|
N/A | |
Completed |
NCT01775865 -
Targeting Inflammation to Treat Cardiovascular Aging
|
Phase 2 | |
Terminated |
NCT01188369 -
Effects of Levosimendan in Patients Eligible for Aortic Valve Replacement With Left Ventricular Hypertrophy
|
Phase 4 | |
Recruiting |
NCT05552521 -
Diastolic Dysfunction in Septic Shock and Cardiomyopathy Genetic Variants
|
||
Recruiting |
NCT05438030 -
Diastolic Function Assessment With Cardiac Magnetic Resonance Imaging
|
N/A | |
Completed |
NCT04128735 -
Diastolic Dysfunction in Morbidly Obese Patients Undergo Bariatric Surgery
|
||
Completed |
NCT00689819 -
Pre-clinical Cardiac Dysfunction Among Asymptomatic Hypertensive Patients
|
N/A | |
Recruiting |
NCT04149990 -
Angiotensin-Neprilysin Inhibition in Diastolic Dysfunction After AMI
|
Phase 2 | |
Completed |
NCT03768752 -
Diastolic Dysfunction and Interstitial Lung Edema in Septic Patients
|
||
Completed |
NCT02932436 -
Effects of Empagliflozin on Left Ventricular Diastolic Function Compared to Usual Care in Type 2 Diabetics
|
Phase 4 | |
Recruiting |
NCT05847244 -
The Effect of Addition of Metformin In Obese Non- Diabetic Patients With Heart Failure With Preserved Ejection Fraction
|
Phase 2 | |
Enrolling by invitation |
NCT04190420 -
The Transition From Hypertension to Hypertensive Heart Disease and Heart Failure, the PREFERS Hypertension Study
|
||
Completed |
NCT04114474 -
Pre-operative Focused Transthoracic Echocardiography for Prediction of Post-operative Cardiac Complications
|
||
Not yet recruiting |
NCT06131008 -
Diastology-Guided Management of Decompensated Heart Failure
|
N/A | |
Completed |
NCT03110614 -
Diastolic Dysfunction and Pauci-inflammatory Acute Exacerbations of COPD
|
||
Not yet recruiting |
NCT02285309 -
Perioperative Measurements of Diastolic Function in Cardiac Surgery
|
N/A | |
Completed |
NCT01761318 -
Effect of Liraglutide on Cardiovascular Endpoints in Diabetes Mellitus Type 2 Patients
|
Phase 4 | |
Completed |
NCT00804518 -
Effect of Exercise on Heart Function in Healthy Elderly People
|
N/A | |
Completed |
NCT00907439 -
Study of the Effect of Inhaled Anesthetics on Diastolic Heart Function Using a Doppler-derived Efficiency Index
|
N/A |